FGEN
FibroGen Inc (FGEN)
$40
About FibroGen Inc (FGEN)
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
Details
Daily high
$0.42
Daily low
$0.35
Price at open
$0.35
52 Week High
$2.93
52 Week Low
$0.18
Market cap
40.3M
Dividend yield
0.00%
Volume
3.4M
Avg. volume
982,390
P/E ratio
-.33
FibroGen Inc News
Details
Daily high
$0.42
Daily low
$0.35
Price at open
$0.35
52 Week High
$2.93
52 Week Low
$0.18
Market cap
40.3M
Dividend yield
0.00%
Volume
3.4M
Avg. volume
982,390
P/E ratio
-.33